Company Overview and News
Environmental Clean Technologies Ltd (ASX:ECT) has signed a binding contract for the sale of Coldry solid fuel in the Victorian market via the provision of a turnkey solution for steam services.
The short term trend of Nifty is positive. It’s moving above the recent negative pattern could be cheering factor for bulls.
IOC HINDCOPPER SUZLON 532938 ARCHIDPLY CAPF TCHQY 532779 532755 532710 532400 KPIT 532541 532187 TORNTPOWER HDFCBANK SADBHAV SUEL NIITTECH ESI INDUSINDBK KMBKY EVSJF 513599 530965 532667 539207 TECHM 532994 HDB 500180 KOTAKBANK 534809 500247 PCJEWELLER MANPASAND
Fundraising: Multiplex operator PVR is evaluating acquisition opportunities of cinema exhibition chains and plans to raise funds to carry out the transaction through issuance of non convertible debentures (NCDs).
IOC SUZLON ARCHIDPLY CAPF TCHQY 532755 532710 532400 KPIT TORNTPOWER 500570 SUEL CLNDY EVSJF 530965 532667 TECHM 532994 500182 500180 520051 KOTAKBANK 534809 PCJEWELLER COALINDIA HINDCOPPER 532938 532779 533278 532541 532187 HDFCBANK HEROMOTOCO SADBHAV TATAMOTORS NIITTECH ESI INDUSINDBK KMBKY IBN 513599 539207 ICICIBANK HDB 532174 JAMNAAUTO HRTQY 500247 MANPASAND TTM
Indian Oil Corporation, which has for decades been India's biggest company by turnover, last week posted a record net profit of Rs 21,346 crore in the fiscal year ended March 31, 2018 (FY 2017-18), up 12 per cent from Rs 19,106 crore in the last fiscal.
IOC 500325 JIPKY BHUSANSTL TCHQY 532755 532754 535754 UCLQY 500570 CLNDY 500055 RLNIY 500413 AXB EVSJF 532627 530965 ULTRACEMCO TECHM 500182 AXBA 500180 520051 TCS COALINDIA RELIANCE PUNJLLOYD GMQRY GMRINFRA 532538 TTNQY 533278 532215 THOMASCOOK 532540 AXISBANK RIGD HDFCBANK HEROMOTOCO TATAMOTORS ORIENTCEM ESI IBN UCLQF JPASSOCIAT 539207 AXBKY 532532 ICICIBANK 532693 HDB 532174 JAMNAAUTO JPPOWER HRTQY MANPASAND TTM
Drug Launch: Pharma major Lupin has launched Solosec (secnidazole) 2g oral granules in the US market, have received an approval from the United States Food and Drug Administration earlier.
500325 JIPKY BHUSANSTL TCHQY 532712 532755 532710 532754 535754 RCOM UCLQY 500570 CLNDY 500055 RLNIY 500413 AXB EVSJF 532627 ULTRACEMCO TECHM 500182 AXBA 500180 520051 TCS COALINDIA RELIANCE PUNJLLOYD GMQRY GMRINFRA 532538 533155 TTNQY JUBLFOOD 533278 532215 THOMASCOOK 532540 AXISBANK RIGD JBLWY HDFCBANK HEROMOTOCO SADBHAV TATAMOTORS ORIENTCEM ESI IBN UCLQF JPASSOCIAT 539207 AXBKY 532532 ICICIBANK 532693 HDB 532174 JAMNAAUTO JPPOWER HRTQY MANPASAND TTM
Environmental Clean Technologies Ltd’s (ASX:ESI) (ECT) shares are trading about 8% higher intra-day at $0.014 after completing the basic design for the Matmor component of its planned India project.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to ASX:ESI / ENVIRONMENTAL CLEAN TECHNOLOGIES LIMITED on message board site Silicon Investor.